ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,363.36
1.81%
US Tech 100
18,164.80
1.78%
다우존스 지수
40,212.71
1.56%
Bitcoin
84,613.02
-0.80%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. USOTC

  6. Hemostemix Inc (QB) (HMTXF) 시세

Hemostemix Inc (QB)

Hemostemix Inc (QB) (HMTXF)

USOTC
0.0661
0.00
(0.00%)
마감 13 4월 5:00AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
0.0661
매수가
0.0001
매도가
0.1699
거래량
-
0.00 일간 변동폭 0.00
0.024 52주 범위 0.285
market_cap
9.363M
전일 종가
0.0661
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
48,564
발행 주식
141,641,969
배당수익률
-
주가수익률
-5.08
주당순이익(EPS)
-0.02
매출
200k
순이익
-2.5M

Hemostemix Inc (QB) 정보

Hemostemix is an autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company has 87 patents on the derivation of angiogenic cell precursors (ACP-01), neuronal cell precursors (NCP-01) and cardiomyocyte cell precursors (CCP-01) fro... Hemostemix is an autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company has 87 patents on the derivation of angiogenic cell precursors (ACP-01), neuronal cell precursors (NCP-01) and cardiomyocyte cell precursors (CCP-01) from a synergetic cell population that is sourced from the patient's blood. The Company is selling exempt compassionate treatments to individuals afflicted with critical limb ischemia, for example, and conducting clinical trials to commercialize its lead product, ACP-01, for the treatment of critical limb ischemia and peripheral arterial disease, and heart disease (ischemic cardiomyopathy, dilated cardiomyopathy). 더 보기

섹터
Pharmaceutical Preparations
산업
Blank Checks
웹사이트
www.hemostemix.com
본부
Calgary, Alberta, Can
설립됨
2014
Hemostemix Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTC 시장 with ticker HMTXF. The last closing price for Hemostemix (QB) was US$0.07. Over the last year, Hemostemix (QB) shares have traded in a share price range of US$ 0.024 to US$ 0.285.

Hemostemix (QB) currently has 141,641,969 shares in issue. The market capitalisation of Hemostemix (QB) is US$9.36 million. Hemostemix (QB) has a price to earnings ratio (PE ratio) of -5.08.

HMTXF 최신 뉴스

추가 뉴스
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.00415-5.907473309610.070250.070250.0636538520.06742406CS
4-0.01845-21.82140745120.084550.087450.054155730.07548437CS
12-0.1333-66.8505516550.19940.2850.054485640.18221022CS
260.0127523.89878163070.053350.2850.0323423000.1597794CS
520.02978.1671159030.03710.2850.024329950.13409111CS
156-0.0839-55.93333333330.150.32790.024250020.14448634CS
2600.0463233.8383838380.01980.43720.0051356940.09583811CS

HMTXF - Frequently Asked Questions (FAQ)

What is the current Hemostemix (QB) share price?
The current share price of Hemostemix (QB) is US$ 0.0661
How many Hemostemix (QB) shares are in issue?
Hemostemix (QB) has 141,641,969 shares in issue
What is the market cap of Hemostemix (QB)?
The market capitalisation of Hemostemix (QB) is USD 9.36M
What is the 1 year trading range for Hemostemix (QB) share price?
Hemostemix (QB) has traded in the range of US$ 0.024 to US$ 0.285 during the past year
What is the PE ratio of Hemostemix (QB)?
The price to earnings ratio of Hemostemix (QB) is -5.08
What is the cash to sales ratio of Hemostemix (QB)?
The cash to sales ratio of Hemostemix (QB) is 64.29
What is the reporting currency for Hemostemix (QB)?
Hemostemix (QB) reports financial results in CAD
What is the latest annual turnover for Hemostemix (QB)?
The latest annual turnover of Hemostemix (QB) is CAD 200k
What is the latest annual profit for Hemostemix (QB)?
The latest annual profit of Hemostemix (QB) is CAD -2.5M
What is the registered address of Hemostemix (QB)?
The registered address for Hemostemix (QB) is SUITE 1150, 707-7TH AVE SW, CALGARY, CALGARY, ALBERTA, T2P 3H6
What is the Hemostemix (QB) website address?
The website address for Hemostemix (QB) is www.hemostemix.com
Which industry sector does Hemostemix (QB) operate in?
Hemostemix (QB) operates in the BLANK CHECKS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
CONNQConns Inc (CE)
US$ 0.003
(299,900.00%)
100
ONPHOncology Pharma Inc (CE)
US$ 0.001
(99,900.00%)
1.44k
STTOSITO Mobile Ltd (CE)
US$ 0.14
(69,900.00%)
278
GOOXFGivot Olam Oil Exploration LP (CE)
US$ 0.04
(19,900.00%)
662
ELIQQElectriq Power Holdings Inc (CE)
US$ 0.02
(19,900.00%)
164
KREDKonaRed Corporation New (CE)
US$ 0.0001
(-99.99%)
71.57k
ZAAGZA Group Inc (PK)
US$ 0.000001
(-99.00%)
366.67k
ABILFAbility Inc (CE)
US$ 0.000001
(-99.00%)
600
SNLPSyntrol Corporation (CE)
US$ 0.000001
(-99.00%)
150
SYHOSynergie Holdings Limited Inc (CE)
US$ 0.000001
(-99.00%)
1,000
SBESSouth Beach Spirits Inc (CE)
US$ 0.0004
(100.00%)
198.93M
AFFUAffluence Corp (PK)
US$ 0.0006
(50.00%)
196.71M
HMBLHUMBL Inc (PK)
US$ 0.0003
(20.00%)
193.54M
TONRTonner One World Holdings Inc (PK)
US$ 0.00015
(-25.00%)
183.27M
CATV4Cable TV International Inc (PK)
US$ 0.0004
(0.00%)
177.71M

HMTXF Discussion

게시물 보기
rodman rodman 2 주 전
Timing is everything!
👍️0
georgie18 georgie18 1 월 전
HMTXF...089...🥳...OTC partnering with a NAZ company sounds promising to me...Calgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely treated 498 patients for various forms of cardiovascular disease, including vascular dementia, announces its collaboration with Firefly Neuroscience, Inc. (NASDAQ: AIFF) ("Firefly"), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders.

Hemostemix and Firefly will study brain wave activity in up to 100 patients before and after treatment with ACP-01 at baseline, 3-months, and 6-months post-treatment (the "Phase 1").

https://www.otcmarkets.com/stock/HMTXF/news/Hemostemix-and-FireFly-Neurosciences-Brain-Network-Analytics-BNATM-Engage-to-Complete-Phase-1-Vascular-Dementia-Clinical?id=469780
👍️0
rodman rodman 2 월 전
Still following Hemostemix? I would be engaged for the short run up!
$1+
👍️0
rodman rodman 2 월 전
Looking like Hemostemix may be an emerging leader in the stem cell arena? Now the recent pr announced the lowest COGS cost of goods in the industry?
$1.+
👍️0
JamesMacho JamesMacho 1 년 전
Investors in $HEM are still waiting for any positive financial data to emerge, but so far, it's been a disappointing journey.
👍️0
tw0122 tw0122 2 년 전
Boom boom time
👍️0

최근 히스토리

USOTC
HMTXF
Hemostemix (QB)
LSE
66VT
Bk. America 25
NASDAQ
MGRX
Mangoceuticals
USOTC
RRRLF
Rockridge Resources (PK)
BOV
CRIN34
Carters
COIN
CHDRUSD
Cheddar Coin
EU
EBEWN
EN BIODIV ENB W NR
BOV
BRGE8
ALFA CONSORCIO PND
BOV
FIQE3R
Unifique Telecomunicacoes ON
ASX
TGA
Thorn
BOV
LEVE3R
METAL LEVE ON
USOTC
ROQAF
Roquefort Therapeutics (PK)
NASDAQ
YY
JOYY
BINA
SNMBTC
SONM
COIN
USDPUSD
Pax Dollar
USOTC
CNGLW
Canna Global Acquisition (CE)
Delayed Upgrade Clock
ADVFN Logo
대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지